Polar Capital Biotechnology I GBP Inc (FUND:B42P0H7) - Overview

Fund Report

Polar Capital Biotechnology Fund I GBP Income

Key Stats
Morningstar® CategorySector Equity Biotechnology
Manager Name-
Inception Date31/10/2013
NAV 31/12/2015GBP 12.39
Day Change-0.08%
12 Month Yield0.00%
ISINIE00B42P0H75
SEDOLB42P0H7
Dividend FrequencyAnnually
Net Assets (mil) 31/08/201682.97 USD
Wrapper AvailabilityAll
Our Minimum Initial Investment1.00 Share
Pricing FrequencyDaily
Dealing Cut off Time16:00:00
Regular InvestmentYes
Actual Initial Charge0.00%
Exit Charge-
Custody ChargeYes
Fund Ongoing Charge1.23%
AMC1.00%
Fund Rebate0.05%

Morningstar Rating™

Not Rated

Morningstar Sustainability Rating

No Rating

No Rating


Sustainability Rating as of -

Benchmarks

Fund Benchmark

NASDAQ Biotechnology TR USD

Morningstar® Benchmark

MSCI World/Biotechnology NR USD

Growth Of 10,000 (GBP) 31/12/2015

How has this security performed
20112012201320142015
Fund---57.8419.48
Category---38.54-
Benchmark---38.93-
  • Fund: Polar Capital Biotechnology Fund I GBP Income
  • Category: Sector Equity Biotechnology
  • Benchmark: MSCI World/Biotechnology NR USD
Trailing Returns % (GBP) 31/12/2015
FundCatBmark
YTD19.48-4.812.46
3 Years Annualised-15.6817.25
5 Years Annualised---
10 Years Annualised---

Morningstar SRRI

Lower Risk
Higher Risk
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
Potentially Lower ReturnsPotentially Higher Returns
Source: Morningstar

Investment Objective

The investment objective of the Fund is to preserve capital and achieve long term capital appreciation.

Portfolio Profile31/08/2016

Morningstar Style Box®

Equity Style

Large, Mid, SmallSize
Value, Blend, Growth
Style
Top Holdings
NameSector%
IncreaseDecreaseNew since last portfolio
IncreaseCelgene Corp Healthcare7.27
DecreaseBiogen Inc Healthcare6.54
IncreaseRegeneron Pharmaceuticals Inc Healthcare6.45
DecreaseActelion Ltd Healthcare6.32
IncreaseGilead Sciences Inc Healthcare6.06
Asset Allocation %
LongShortNet
Stocks100.440.00100.44
Bonds0.000.000.00
Cash0.000.44-0.44
Other0.000.000.00
Top Stock Regions
Region%
United States78.39
Europe - ex Euro12.88
Eurozone5.90
United Kingdom2.60
Canada0.23
Top Stock Sectors
Stock Sector%
Healthcare100.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.